Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies.

[1]  Stephen J Verzi,et al.  Potential Public Health Effects of Reducing Nicotine Levels in Cigarettes in the United States , 2018, The New England journal of medicine.

[2]  C. Katlama,et al.  Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial. , 2018, The lancet. HIV.

[3]  G. Guaraldi,et al.  Geriatric-HIV Medicine Is Born. , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  E. Siegler,et al.  From One Syndrome to Many: Incorporating Geriatric Consultation Into HIV Care , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  R. Walensky,et al.  Charting the Future of Infectious Disease: Anticipating and Addressing the Supply and Demand Mismatch. , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  B. Vogelstein,et al.  Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention , 2017, Science.

[7]  M. Johnson,et al.  Immediate Antiretroviral Therapy Reduces Risk of Infection-Related Cancer During Early HIV Infection. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  K. Althoff.  The Shifting Paradigm of Care for Adults Living With HIV: Smoking Cessation for Longer Life. , 2016, The Journal of infectious diseases.

[9]  P. Reiss,et al.  HIV and ageing: improving quantity and quality of life , 2016, Current opinion in HIV and AIDS.

[10]  P. Easterbrook,et al.  Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. , 2016, The Lancet. Infectious diseases.

[11]  K. Crothers,et al.  Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis , 2016, AIDS.

[12]  A. Marshall,et al.  Assessing violations of the proportional hazards assumption in Cox regression: does the chosen method matter? , 2015, Trials.

[13]  Richard D Moore,et al.  Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. , 2015, Annals of internal medicine.

[14]  Richard D Moore,et al.  End-stage renal disease among HIV-infected adults in North America. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  J. Skarbinski,et al.  Cigarette Smoking Prevalence Among Adults With HIV Compared With the General Adult Population in the United States , 2015, Annals of Internal Medicine.

[16]  J. Margolick,et al.  The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation , 2015, AIDS.

[17]  Richard D Moore,et al.  Ascertainment and Verification of End-Stage Renal Disease and End-Stage Liver Disease in the North American AIDS Cohort Collaboration on Research and Design , 2015, AIDS research and treatment.

[18]  M. Tsai,et al.  Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review. , 2014, World journal of gastroenterology.

[19]  E. Moodie,et al.  Mortality in HIV–hepatitis C co-infected patients in Canada compared to the general Canadian population (2003–2013) , 2014, AIDS.

[20]  O. Kirk,et al.  Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration , 2014, The Lancet.

[21]  C. Boyd,et al.  Patient-centered care for people living with multimorbidity. , 2014, Current opinion in HIV and AIDS.

[22]  Mardge H. Cohen,et al.  Smoking cessation and recidivism in the Women's Interagency Human Immunodeficiency Virus Study. , 2014, American journal of preventive medicine.

[23]  M. Budoff,et al.  Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts. , 2014, American journal of epidemiology.

[24]  R. Weber,et al.  Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study , 2013, HIV medicine.

[25]  Tommi Härkänen,et al.  SAS Macros for Calculation of Population Attributable Fraction in a Cohort Study Design , 2011 .

[26]  M. Elisaf,et al.  Dyslipidemia Associated with Chronic Kidney Disease , 2011, The open cardiovascular medicine journal.

[27]  S. Deeks,et al.  HIV infection, inflammation, immunosenescence, and aging. , 2011, Annual review of medicine.

[28]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[29]  D. Klein,et al.  Antiretroviral therapy as a cardiovascular disease risk factor: fact or fiction? A review of clinical and surrogate outcome studies , 2008, Current opinion in HIV and AIDS.

[30]  F. Schmidt.  Meta-Analysis , 2008 .

[31]  Richard D Moore,et al.  Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). , 2007, International journal of epidemiology.

[32]  O. Kirk,et al.  Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study , 2003, AIDS.

[33]  Richard D Moore,et al.  Hepatitis C and progression of HIV disease. , 2002, JAMA.

[34]  Richard Doll,et al.  Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies , 2000, BMJ : British Medical Journal.

[35]  John W. Ward,et al.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[36]  S. Walter.  The estimation and interpretation of attributable risk in health research. , 1976, Biometrics.

[37]  A. B. Hill.  The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.

[38]  A. Mocroft,et al.  Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study. , 2016, The lancet. HIV.

[39]  C. Weinberg,et al.  Use and misuse of population attributable fractions. , 1998, American journal of public health.